Yingtukang closes a RMB 100 million Series D funding round, with joint investment from Yuanhe Chencun.

2021-05-27

Recently, Suzhou Intucon Medical Technology Co., Ltd. (hereinafter referred to as "Intucon"), a global leader in electric staplers, announced the completion of a RMB 100-million-level Series D funding round. This round was led by Qiming Venture Partners, with participation from Yuanhe Holdings and Yuanhe Chencun...

Xu Qing from Yuanhe Chencun and Kun: How S Funds Can Enhance LPs' Capital Efficiency to Support Emerging Industries

2021-04-30

On April 29, 2021, Xu Qing, Managing Partner at Yuanhe Chencun, attended the 8th Global M&A Summit and delivered a keynote speech.

Yuanhe Chencun's Wang Jipeng: Industrial and private capital are poised to become emerging forces in China's long-term investment landscape.

2021-03-22

On March 19, 2021, the "Tide Rising" 2021 China Fund-of-Funds Annual Conference was held in Shanghai, where Wang Jipeng, Senior Partner at Yuanhe Chencun, participated in the roundtable discussion session.

New Consumer Trends in Modern Business | Yuanhe Chencun Successfully Hosts the First "Kunpeng Hui·Industry Salon"

2021-03-08

Yuanhe Chencun hosted the first session of its 2021 "Kunpeng Hui" ecosystem industry salon series at Dongsha Lake Fund Town. This event focused on the To C sector, with the theme "New Consumer Trends in Modern Commerce."

Xu Qing from Yuanhe Chencun: Fund-of-Funds Drives Technological Innovation and Regional Economic Development

2021-03-08

On March 7, 2021, Xu Qing, Managing Partner of Yuanhe Chencun, attended the 2021 China Fund-of-Funds Annual Kickoff Conference and delivered a keynote speech.

Xinhai Technology Successfully Launches IPO, Adding Another Member to Yuanhe Chencun's STAR Market Portfolio

2020-09-28

On September 28, 2020, the flagship fund portfolio managed by Yuanhe Chencun added another STAR Market-listed company—Xinhai Technology (Shenzhen) Co., Ltd. (referred to as "Xinhai Technology," stock code "688595"), with an investment from the Fangguang Phase II Fund.